| Income Statement |
| Total Revenue | 13.82M |
|
| Revenues (USD) | 13.82M |
| Cost of Revenue | 11.44M |
| Gross Profit | 2.38M |
| Operating Expenses | 9.33M |
| Research and Development Expense | 2.70M |
| Selling, General and Administrative Expense | 6.63M |
| Operating Income | -6.95M |
| Interest Expense | 733.00K |
| Income Tax Expense | 26.00K |
| Net Income | -7.00M |
| Net Income Common Stock | -7.00M |
| Net Income Common Stock (USD) | -7.00M |
| Consolidated Income | -7.00M |
| Earnings per Basic Share | -0.28 |
| Earnings per Basic Share (USD) | -0.28 |
| Earnings per Diluted Share | -0.28 |
| Earning Before Interest & Taxes (EBIT) | -6.24M |
| Earning Before Interest & Taxes (USD) | -6.24M |
| Weighted Average Shares | 25.02M |
| Weighted Average Shares Diluted | 25.02M |
| Balance Sheet |
| Cash and Equivalents | 16.56M |
| Cash and Equivalents (USD) | 16.56M |
| Trade and Non-Trade Receivables | 6.73M |
| Current Assets | 65.17M |
| Property, Plant & Equipment Net | 17.44M |
| Total Assets | 92.40M |
| Debt Current | 3.14M |
| Total Debt | 9.17M |
| Current Liabilities | 26.62M |
| Debt Non-Current | 6.04M |
| Total Liabilities | 40.86M |
| Accumulated Retained Earnings (Deficit) | -505.14M |
| Shareholders Equity | 51.54M |
| Shareholders Equity (USD) | 51.54M |
| Assets Non-Current | 27.23M |
| Total Debt (USD) | 9.17M |
| Deferred Revenue | 7.74M |
| Inventory | 28.10M |
| Liabilities Non-Current | 14.25M |
| Trade and Non-Trade Payables | 9.09M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 821.00K |
| Net Cash Flow from Financing | -3.53M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -22.45M |
| Capital Expenditure | -940.00K |
| Issuance (Repayment) of Debt Securities | -3.53M |
| Net Cash Flow from Investing | -940.00K |
| Net Cash Flow from Operations | -17.98M |
| Effect of Exchange Rate Changes on Cash | -1000 |
| Share Based Compensation | 1.89M |